|
End-of-day quote
Korea S.E.
13/10/2026
|
5-day change | 1st Jan Change | ||
| 14,770.00 KRW | -6.58% |
|
-19.38% | -74.27% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-22 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.58% | -19.38% | -12.45% | -34.21% | -74.27% | -63.35% | - | - | - | 165M | |
| -0.32% | -5.97% | +4.04% | +30.86% | +73.60% | +57.78% | +74.48% | +5.60% | - | 70.44B | |
| +0.92% | -13.50% | -16.41% | -4.70% | +1.20% | +5.56% | +54.34% | +179.97% | +4,771.73% | 50.31B | |
| +2.77% | +0.90% | +9.02% | 0.00% | +8.29% | +11.27% | +36.68% | -19.02% | +220.00% | 47.51B | |
| -0.58% | +0.27% | -0.42% | +25.60% | +15.65% | +27.93% | +30.76% | +7.94% | +244.36% | 42.91B | |
| -2.84% | -5.72% | -7.52% | +2.44% | +136.59% | +286.54% | +530.02% | +577.35% | - | 40.39B | |
| -0.38% | -3.78% | +0.74% | +14.84% | +14.90% | +6.74% | +95.25% | -2.06% | +992.24% | 39.69B | |
| -0.39% | -1.48% | +0.84% | +2.63% | +4.25% | +10.41% | +43.19% | +1.43% | +150.46% | 30.59B | |
| -2.95% | -12.28% | +1.22% | +30.21% | +58.21% | +43.51% | +1.51% | -54.53% | - | 26.8B | |
| -7.13% | -7.02% | -7.98% | -1.18% | -6.50% | -12.99% | -14.07% | -64.31% | - | 22.36B | |
| -1.30% | -1.81% | +15.41% | +31.29% | +20.47% | +17.12% | +8.53% | -12.85% | +117.45% | 22.1B | |
| -1.80% | -8.02% | -25.21% | -11.32% | -44.39% | -40.96% | +290.91% | +235.73% | +585.48% | 21.14B | |
| -1.64% | +1.16% | +3.81% | +15.03% | +8.59% | +15.64% | +155.08% | +232.27% | +1,954.19% | 17.02B | |
| -1.69% | -0.85% | -8.98% | -6.80% | +174.96% | +147.10% | +355.27% | +1,802.01% | +728.97% | 15B | |
| -0.97% | +1.54% | +7.68% | +12.61% | +24.52% | +25.28% | +54.17% | -29.47% | +85.93% | 15.25B | |
| -1.67% | -1.26% | -15.30% | -15.84% | - | - | - | - | - | 14.66B | |
| -0.52% | +2.02% | +6.04% | +6.19% | +35.77% | +54.81% | +178.60% | +177.44% | +399.66% | 14.75B | |
| -0.94% | -1.95% | +7.46% | +30.15% | +49.90% | +75.23% | +56.54% | -25.77% | +269.57% | 14.27B | |
| -2.84% | -6.70% | -9.14% | -12.24% | +11.47% | -2.02% | +438.42% | - | - | 13.7B | |
| -9.40% | -10.34% | -11.57% | +1.44% | -11.26% | -32.32% | +823.81% | +189.55% | +48.80% | 12.41B | |
| Average | -1.50% | -4.68% | -2.94% | +5.85% | +26.42% | +33.33% | +178.53% | +188.31% | +812.99% | 26.57B | |
| Weighted average by Cap. | -0.86% | -4.61% | -1.82% | +10.39% | +34.57% | +44.37% | +139.52% | +137.38% | +1,095.81% |
- Stock Market
- Stocks
- A287840 Stock
- Sector IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
